Clinical Trials at Augusta University
As of June 2026, 42 paid clinical trials are recruiting at Augusta University, located at 1120 15TH ST, AUGUSTA, GA 30912-0004, phone (706) 721-6597 in Augusta, Georgia. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Ovarian Cancer and Sickle Cell Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
42 clinical trials at Augusta University
·Clear filters·↓ Download CSVA Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Assessing Obesity Related Risk Factors in Adult Population: A Genetic and Behavioral Study
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Assessing Improvements in Mood and Sleep Trial
A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia
Lifestyle Intervention for Healthy Change
The Impact of Meditation on Anxiety and Post-Operative Pain in Pediatric Patients Undergoing Urological Surgery
BREATHE Free: a Pilot Feasibility Trial
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Long-term Safety and Tolerability of BHV-7000
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Virtual Reality During Exercise Testing
Mobile App Logging for Diabetes in Pregnancy
CraniSeal Post Approval Study
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
Thoracic Neuromodulation for Diabetic Gastroparesis
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
HEALEY ALS Platform Trial - Master Protocol
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
About research studies in Augusta
Augusta has approximately 206 recruiting research studies across a wide range of therapeutic areas. Georgia is home to Emory University Hospital, Winship Cancer Institute, and Children's Healthcare of Atlanta, with active research in oncology, infectious disease, and cardiovascular health.
Common conditions studied in Augusta
- Acute Myeloid Leukemia (7 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Ovarian Cancer (6 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.
- Sickle Cell Disease (6 active studies). Sickle cell disease studies test gene therapies, gene editing, and new small molecules aimed at reducing pain crises and organ damage.
- Cervical Cancer (4 active studies). Recruiting Cervical Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Endometrial Cancer (4 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Generalized Myasthenia Gravis (4 active studies). Recruiting Generalized Myasthenia Gravis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Augusta
- Augusta University
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- SWOG Cancer Research Network
Local regulations and guidelines
Clinical trials in Georgia are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Georgia research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Augusta. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Augusta
Hipa.ai aggregates every recruiting study in Augusta from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Augusta?
There are approximately 206 recruiting clinical trials in Augusta, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Augusta pay participants?
Most recruiting trials in Augusta compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Augusta?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Augusta?
The most common conditions under active study in Augusta include Acute Myeloid Leukemia (7), Ovarian Cancer (6), Sickle Cell Disease (6), Cervical Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Augusta?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Augusta on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Augusta?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Augusta?
Recruiting research sites in Augusta include Augusta University Medical Center, Augusta University, Georgia Cancer Center at Augusta University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Augusta right now?
The largest active categories in Augusta are Cancer & tumors (77), Eye & vision (12), Neurology & pain (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Augusta University?
Augusta University is located at 1120 15TH ST, AUGUSTA, GA 30912-0004. Use the Google Maps link in the intro above to get directions.
How do I contact Augusta University?
You can reach Augusta University by phone at (706) 721-6597. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.